Massey physician-researcher awarded $250,000 to identify risk factors for the prevention and treatment of pediatric cancer
Seth Corey, M.D., chief of the Division of Hematology, Oncology and Stem Cell Transplantation in the Department of Pediatrics at VCU Massey Cancer Center and the Children’s Hospital of Richmond at VCU, received a $250,000 Innovation award from Alex’s Lemonade Stand Foundation (ALSF) to determine which children with an inherited bone marrow failure syndrome would benefit most from stem cell transplantation at an early stage using precision medicine and computer models.
With Cutting-Edge Immunotherapy, Amy Boles Defies The Odds of Advanced Melanoma
Amy Boles sat on a stool next to the doctor she credits with saving her life as she shared her experience with a deadly form of skin cancer that spread and nearly consumed her entire liver.
Massey researcher studies the relationship of cholesterol to cancer growth
VCU Massey Cancer Center researcher Gregorio Gil, Ph.D., studies the functions of cholesterol in the development of colon cancer in order to identify targets for novel therapies to treat or prevent the disease.
Study uncovers potential ‘silver bullet’ for preventing and treating colon cancer
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential “silver bullet” for preventing and treating it. The findings may extend to ovarian, breast, lung, prostate and potentially other cancers that depend on the same mechanism for growth.
Massey re-designated by the National Cancer Institute for the 42nd year
Virginia’s first cancer center designated by the National Cancer Institute, VCU Massey Cancer Center, has renewed its NCI designation for the 42nd year. The prestigious distinction was given to Massey for demonstrating superior capabilities in cancer education and in researching new and better cancer treatments as well as methods for prevention, detection and survivorship. Massey’s renewal as an NCI-designated cancer center extends to 2022 and includes a Cancer Center Support Grant of $11 million to support research, clinical trials, education and training.